87 related articles for article (PubMed ID: 3292485)
21. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
22. Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease.
Vriesendorp HM; Quadri SM
Cancer Biother Radiopharm; 2000 Oct; 15(5):431-45. PubMed ID: 11155816
[TBL] [Abstract][Full Text] [Related]
23. [131I antiferritin in the treatment of hepatoma and Hodgkin's disease].
Cohen Y; Moroz H
Harefuah; 1986 Dec; 111(11):398-9. PubMed ID: 3028919
[No Abstract] [Full Text] [Related]
24. Antibody-based targeted radiation to pediatric tumors.
Modak S; Cheung NK
J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
[TBL] [Abstract][Full Text] [Related]
25. Magnetically enhanced radionuclide therapy.
Raylman RR; Wahl RL
J Nucl Med; 1994 Jan; 35(1):157-63. PubMed ID: 8271038
[TBL] [Abstract][Full Text] [Related]
26. Radiolabeling of antibodies for therapy and diagnosis.
Baranowska-Kortylewicz J; Dalrymple GV; Quadri SM; Harrison KA
Methods Mol Biol; 1995; 51():423-39. PubMed ID: 7581715
[No Abstract] [Full Text] [Related]
27. Antibody-targeted therapy for myeloid leukemia.
Appelbaum FR
Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
[TBL] [Abstract][Full Text] [Related]
28. A proposal for a new direction to treat cancer.
Rose S
J Theor Biol; 1998 Nov; 195(1):111-28. PubMed ID: 9802954
[TBL] [Abstract][Full Text] [Related]
29. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
30. Radiolabeled antibody therapy of B-cell lymphomas.
Press OW
Semin Oncol; 1999 Oct; 26(5 Suppl 14):58-65. PubMed ID: 10561019
[TBL] [Abstract][Full Text] [Related]
31. Brief overview of preclinical and clinical studies in the development of intraperitoneal radioimmunotherapy for ovarian cancer.
Meredith RF; Buchsbaum DJ; Alvarez RD; LoBuglio AF
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5643s-5645s. PubMed ID: 17875801
[TBL] [Abstract][Full Text] [Related]
32. 90Yttrium antiferritin--a new therapeutic radiolabeled antibody.
Order SE; Klein JL; Leichner PK; Frincke J; Lollo C; Carlo DJ
Int J Radiat Oncol Biol Phys; 1986 Feb; 12(2):277-81. PubMed ID: 3005201
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma.
Juweid ME; Stadtmauer E; Hajjar G; Sharkey RM; Suleiman S; Luger S; Swayne LC; Alavi A; Goldenberg DM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3292s-3303s. PubMed ID: 10541378
[TBL] [Abstract][Full Text] [Related]
34. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
[TBL] [Abstract][Full Text] [Related]
35. [Radioimmunotherapy of lymphomas and leukemias].
Rain JD; Billotey C
Pathol Biol (Paris); 1998 May; 46(5):341-5. PubMed ID: 9769896
[TBL] [Abstract][Full Text] [Related]
36. Phase I-II study of radiolabeled antibody integrated in the treatment of primary hepatic malignancies.
Order SE; Klein JL; Ettinger D; Alderson P; Siegelman S; Leichner P
Int J Radiat Oncol Biol Phys; 1980 Jun; 6(6):703-10. PubMed ID: 6256319
[No Abstract] [Full Text] [Related]
37. Current status of radioimmunoglobulins in the treatment of human malignancy.
Order SE; Sleeper AM; Stillwagon GB; Klein TL; Leichner PK
Oncology (Williston Park); 1989 May; 3(5):115-20; discussion 122, 129-30. PubMed ID: 2491440
[TBL] [Abstract][Full Text] [Related]
38. Manual on the proper use of yttrium-90-labeled anti-P-cadherin antibody injection for radionuclide therapy in clinical trials.
Hosono M; Ikebuchi H; Kinuya S; Yanagida S; Nakamura Y; Yamada T; Sakaguchi K; Sugano H; Kojima K; Hatazawa J
Ann Nucl Med; 2019 Nov; 33(11):787-805. PubMed ID: 31606788
[TBL] [Abstract][Full Text] [Related]
39. International Clinical Trials in Radiation Oncology. Intraoperative trials.
Calvo FA; Hanks GE
Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S111-7. PubMed ID: 3292468
[No Abstract] [Full Text] [Related]
40. Yttrium-90 for cancer therapy studies secured through Government and commercial suppliers.
Tilyou SM
J Nucl Med; 1991 Feb; 32(2):16N-20N. PubMed ID: 1992017
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
